Showing results (171-180 of 409) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|June 1, 2026
Integrating multi-omics analysis and machine learning to refine molecular subtypes and prognostic assessment of lower-grade gliomaQian Jiang, Ai-Yu Yang, Guan-Ling Mo, et al.
Molecular Therapy. Oncology|June 8, 2026
Comparison of the in vivo biodistributions of αvβ6-binding agents for PET imaging applicationsEmma A Swift, Stephen J Paisey, Toby J Phesse, et al.
Molecular Therapy. Oncology|August 2, 2026
Retraction Notice to: Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibitionXiangyi He, Yunwei Sun, Rong Fan, et al.
Molecular Therapy. Oncology|July 28, 2026
Pediatric AML CAR T cell therapyAnand S Bhagwat, Swati Naik
Molecular Therapy. Oncology|July 19, 2026
Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroidsMadeleine Birgersson, Monika Lukoseviciute, Ourania N Kostopoulou, et al.
Molecular Therapy. Oncology|June 19, 2026
The miR-16-1-3p suppresses proliferation and invasiveness via the MDM2-p53 axis in TGF-β1 signaling in osteosarcomaWenyu Xue, Yuzhe Wang, A V Smirnova, et al.
Molecular Therapy. Oncology|April 17, 2026
A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanomaDaniel Stauber, Lucas Sosnick, Yitong Ma, et al.
Molecular Therapy. Oncology|April 30, 2026
Oncolytic virotherapy mobilizes tumor-resident, granzyme B-producing bystander CD4+ T cells to inhibit systemic microbial infectionShuai Yue, Junjian He, Shusen Ye, et al.
Molecular Therapy. Oncology|May 6, 2026
NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approachYuchen Chen, Zuoyu Jiang, Sen Jin, et al.
Molecular Therapy. Oncology|April 20, 2026
Chimeric antigen receptor T cell targeting CD44E variant in HCC holds therapeutic potentialRui Liao, Cecilia Ka Wing Chan, Yuanbin Cui, et al.
Pageof 41